5
b,7,8
the ajmaline-related alkaloids perakine (5)
5
and rau-
acetylene in 95% yield. The optically active R-propargylic
alcohol 10 [enantiomeric ratio (er) = 90:10] was synthe-
sized from 9 via a two step oxidation/asymmetric hydro-
genation sequence under the conditions developed by
Marshall et al. for the S-propargylic alcohol. The asym-
metric hydrogenation was performed on a 25 g scale with
little erosion of the er. Treatment of the optically active R-
alcohol 10with2.2 equiv oftosyl chloride in the presence of
b,7,9
caffrinoline (6)
macrosalhine chloride, peraksine, verticillatine, 10-metho-
illustrated in Figure 1, as well as
5
5
5
5
b,7
5b,7
and vincawajine. No enantiospecific total
xyperakine,
1
5
synthesis of this class of sarpagine-ajmaline alkaloids has
appeared to date.
4
3
equiv of triethylamine at ꢀ25 °C in dichloromethane for
.5 h provided the R-tosylate 11. An S 2 alkylation of the
N
N -nitrogen function in 8 with the tosylate 11 took place
b
smoothly in dry acetonitrile/K CO to provide the alky-
2
3
lated ketone which was then treated with tetrabutylammo-
nium fluoride (TBAF xH O) at 0 °C in THF to provide
3
2
the acetylenic ketone 12 in 96% yield (Scheme 1).
Scheme 1. Synthesis of the Acetylenic Ketone 12
Figure 1. Sarpagine-ajmaline alkaloids containing additional
chiral centers at C-19(S) and C-20(R).
An objective of this research effort was to gain entry into
the C-19 methyl substituted sarpagine series which would
permit a study of the potential synthesis of the northern
1
0
hemisphere of the bisindole alkaloid macrospegatrine,
and the basic pentacylic framework 14 would also serve as
the template for the synthesis of the biogenetically impor-
tant ajmaline alkaloids, perakine (5) and raucaffrinoline
The simplest method for converting terminal alkynes to
16
vinyl iodides in a single step is by the use of HI which is
not useful especially for sensitive substrates. Although
1
1
(
6). The fact that a biogenetic link exists between the
sarpagine and ajmaline alkaloids proposed by St o€ ckigt
17
other methods are reported to achieve this important
1
2
et al. can be employed to achieve this interconversion.
Herein we report the first enantiospecific total synthesis of
the C-19 substituted sarpagine indole alkaloids (þ)-dihy-
droperaksine-17-al (1) and (þ)-dihydroperaksine (2).
The synthesis began with the enantiospecific, stereospe-
cific preparation of the (ꢀ)-N -H, N -H tetracyclic ketone
conversion, there are very few reports on the direct synth-
18
esis of R-vinyl iodides from terminal alkynes. In 1983
Suzuki et al. reported the regioselective haloboration of
19
terminal alkynes with B-bromo- or B-iodo-9-BBN [BBN:
borabicyclo(3.3.1)nonane] tofurnish the respectiveR-vinyl
halides in excellent yields and very high regioselectivities.
Initial attempts at haloboration of 12, under these
a
b
8
from D-tryptophan methyl ester 7 on a multihundred
gram scale following the procedure developed in Milwau-
1
3
kee. In order to introduce the desired stereocenter at
C-19 into the sarpagan skeleton, the synthesis of the
optically active R-acetylenic tosylate 11 was carried out as
illustrated in Scheme 1. The racemic TIPS propargylic
alcohol 9 was synthesized according to the procedure of
(15) Marshall, J. A.; Eidam, P.; Eidam, H. S. Org. Synth. 2007, 84,
1
20.
(
16) Smith, M. B.; March, J. March’s Advanced Organic Chemistry:
Reactions, Mechanisms, and Structure, 6th ed.; Wiley-Interscience: Hobo-
ken, NJ, 2007; Chapter 15, pp 999ꢀ1250.
1
4
(17) (a) Katagiri, T.; Fujiwara, K.; Kawai, H.; Suzuki, T. Tetrahe-
dron Lett. 2008, 49, 3242. (b) Va, P.; Roush, W. R. Tetrahedron 2007, 63,
Jones et al. from commercially available triisopropylsilyl
5
1
768. (c) Nielsen, T. E.; Le Quement, S.; Tanner, D. Synthesis 2004,
381. (d) Kazmaier, U.; Pohlman, M.; Schauss, D. Eur. J. Org. Chem.
(
(
(
9) Libot, F.; Kunesch, N.; Poisson, J. Phytochemistry 1980, 19, 989.
10) Lin, X.; Zheng, Q.; Zhang, Y. J. Struct. Chem. 1987, 6, 89.
11) Takayama, H.; Phisalaphong, C.; Kitajima, M.; Aimi, N.; Sakai,
2000, 2761. (e) Kikukawa, K.; Umekawa, H.; Wada, F.; Matsuda, T.
Chem. Lett. 1988, 881.
(18) (a) Gao, F.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 10961.
(b) Kawaguchi, S.; Ogawa, A. Org. Lett. 2010, 12, 1893. (c) Campos,
S.; St o€ ckigt, J. Chem. Pharm. Bull. 1991, 39, 266.
12) (a) Pfitzner, A.; St o€ ckigt, J. Tetrahedron Lett. 1983, 24, 5197.
b) Ruppert, M.; Ma, X.; St o€ ckigt, J. Curr. Org. Chem. 2005, 9, 1431.
13) Yu, P.; Wang, T.; Li, J.; Cook, J. M. J. Org. Chem. 2000, 65,
173.
14) Jones, G. B.; Wright, J. M.; Plourde, G. W., II; Hynd, G.; Huber,
(
P. J.; Garcıa, B.; Rodrıguez, M. A. Tetrahedron Lett. 2002, 43, 6111.
´ ´
(
(d) Reddy, C. K.; Periasamy, M. Tetrahedron Lett. 1990, 31, 1919.
(e) Kamiya, N.; Chikami, Y.; Ishii, Y. Synlett 1990, 675. (f) Gras, J.-L.;
Kong Win Chang, Y. Y.; Bertrand, M. Tetrahedron Lett. 1982, 23, 3571.
(19) (a) Hara, S.; Dojo, H.; Takinami, S.; Suzuki, A. Tetrahedron
Lett. 1983, 24, 731. (b) Suzuki, A. Rev. Heteroatom. Chem. 1997, 17, 271.
(
3
(
R. S.; Mathews, J. E. J. Am. Chem. Soc. 2000, 122, 1937.
Org. Lett., Vol. 13, No. 19, 2011
5217